EUROIMMUN Logo
Find
X

What are you looking for?

Filter for products in our complete portfolio

Product finder

Worldwide
X
EUROIMMUN worldwide

This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information

EUROIMMUN branches

Choose your country

Europe

North America

South & Central America

Asia

Middle East & Africa

EUROIMMUN Logo

Whooping cough: case numbers on the rise

Coughing Woman in white t-shirt

After a longer break due to the COVID protection measures, case numbers now return to their pre-pandemic levels in many countries.

According to the European Centre for Disease Prevention and Control (ECDC) for EU/EEA more than 25,000 cases of pertussis were reported in 2023, and more than 32,000 between January and March 2024.1

Despite overall high vaccination rates (against the causative agent Bordetella (B.) pertussis), the disease remains one of the leading causes of vaccine-preventable deaths worldwide. Unvaccinated or incompletely vaccinated babies under one year of age are most at risk of serious illness and death. In 2018, the World Health Organization (WHO) reported 151,074 whooping cough cases globally and estimated that there were 89,000 deaths due to the disease.2

1 ECDC: Increase of pertussis cases in the EU/EEA - as of 8 May 2024

2 CDC: Pertussis in Other Countries - as of 2 April 2024

Infection diagnostics with EUROIMMUN

As whooping cause often does not present with the classic symptoms, particularly in adults, but also in older children and adolescents, laboratory diagnostics are crucial to support a diagnosis.

EUROIMMUN provides PCR-based direct pathogen detection and various serological test systems as well as corresponding automation solutions for reliable whooping cough diagnostics.

Other relevant parameters:

Measles virus        Tick-borne infections

Rendering, Virus globe lying on a palm

Thinking globally – acting locally
With over 35 years of experience in the field of laboratory diagnostics, we develop and globally distribute complete diagnostic solutions that are tailored to your local needs. Working together with local health and scientific authorities we stay aware of novel and/or urgent infection events and deliver appropriate solutions for infectious diseases diagnostics all over the world. With our unrivalled in-house development and production of diagnostic test systems as well as our automation and software solutions, we are able to respond rapidly to both small and large infection outbreaks, providing support to national and international health entities when and where it is needed.
Thinking globally – acting locally

To differentiate between whooping cough and other coughing illnesses

ELISA

Immunoblot

  • EUROLINE Bordetella pertussis (IgG)
    → Data sheet (PDF)
    Order no. DN 2050-1601 G
  • EUROLINE Bordetella pertussis (IgA)
    Order no. DN 2050-1601 A

PCR

  • GeneProof Bordetella pertussis/parapertussis PCR Kit
    (manufactured by GeneProof)
    Order no. MH 0039

Find out more about our test portfolio

Infections

 
 

EUROIMMUN's solutions for infection diagnostics

in Europe

Thumbnail design - outline from Europe, Virus Icon on green background
 
 

More information

Contact

If you have any questions, please do not hesitate to contact us:

Product Management Infection Diagnostics

infection-pm(at)euroimmun.de

Or get in touch with your local contact person

Find your local distributor

 
 

Editorial: Diagnostics for vaccine-preventable diseases

Laboratory tests for vaccine-preventable diseases support diagnosis of acute cases and determination of individual immune status. EUROIMMUN offers an extensive portfolio of serological tests for detection of IgG and IgM antibodies against different pathogens, together with PCR-based assays for direct detection of selected parameters.
Read more

Featured in Practical Patient Care, April 2025

Back to top